Education
About Us
Working with TipRanks
Follow Us
Neurocrine (NBIX)
NASDAQ:NBIX
Total Valuation
Neurocrine has a market cap or net worth of $9.39B. The enterprise value is $13.47B.
Market Cap$9.39B
Enterprise Value$13.47B
Share Statistics
Neurocrine has 98.94M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding98.94M
Owned by Insiders1.09%
Owned by Instutions0.64%
Financial Efficiency
Neurocrine’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 12.48%.
Return on Equity (ROE)13.18%
Return on Assets (ROA)9.18%
Return on Invested Capital (ROIC)12.48%
Return on Capital Employed (ROCE)17.77%
Revenue Per Employee$1,308,499.999
Profits Per Employee$189,611.111
Employee Count1,800
Asset Turnover0.63
Inventory Turnover0.59
Valuation Ratios
The current PE Ratio of Neurocrine is 40.15. Neurocrine’s PEG ratio is 1.22.
PE Ratio40.15
PS Ratio5.82
PB Ratio5.29
Price to Fair Value5.29
Price to FCF24.60
Price to Operating Cash Flow23.02
PEG Ratio1.22
Income Statement
In the last 12 months, Neurocrine had revenue of $2.36B and earned $341.30M in profits. Earnings per share was $3.38.
Revenue$2.36B
Gross Profit$2.31B
Operating Income$579.00M
Pretax Income$486.00M
Net Income$341.30M
EBITDA610.10M
Earnings Per Share (EPS)3.38
Cash Flow
In the last 12 months, operating cash flow was $595.40M and capital expenditures -$38.20M, giving a free cash flow of $557.20M billion.
Operating Cash Flow$595.40M
Free Cash Flow$557.20M
Free Cash Flow per Share$5.63
Dividends & Yields
Neurocrine pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield4.07%
Earnings Yield2.49%
Stock Price Statistics
Beta0.66
52-Week Price Change-27.69%
50-Day Moving Average112.59
200-Day Moving Average127.45
Relative Strength Index (RSI)39.00
Average Volume (3m)1.47M
Important Dates
Neurocrine upcoming earnings date is May 5, 2025, After Close.
Last Earnings DateFeb 6, 2025
Next Earnings DateMay 5, 2025
Ex-Dividend Date―
Financial Position
Neurocrine as a current ratio of 3.40, with Debt / Equity ratio of 0.18
Current Ratio3.40
Quick Ratio3.28
Debt to Market Cap0.03
Net Debt to EBITDA0.36
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Neurocrine has paid $144.70M in taxes.
Income Tax$144.70M
Effective Tax Rate29.77%
Enterprise Valuation
Neurocrine EV to EBITDA ratio is 22.83, with an EV/FCF ratio of 24.99.
EV to Sales5.91
EV to EBITDA22.83
EV to Free Cash Flow24.99
EV to Operating Cash Flow23.39
Balance Sheet
Neurocrine has $1.08B in cash and marketable securities with $455.10M in debt, giving a net cash position of -$621.00M billion.
Cash & Marketable Securities$1.08B
Total Debt$455.10M
Net Cash-$621.00M
Net Cash Per Share-$6.28
Tangible Book Value Per Share$25.43
Margins
Gross margin is 98.56%, with operating margin of 24.22%, and net profit margin of 14.49%.
Gross Margin98.56%
Operating Margin24.22%
Pretax Margin20.63%
Net Profit Margin14.49%
EBITDA Margin25.90%
EBIT Margin24.75%
Analyst Forecast
The average price target for Neurocrine is $160.45, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$160.45
Price Target Upside66.86%
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast24.81%
EPS Growth Forecast33.67%